RapidAI operates a neuroimaging platform designed to generate high-resolution images from non-contrast scans. The platform allows for the viewing, processing, and analysis of brain images, thereby enabling clinicians to make well-informed diagnostic and treatment decisions for stroke patients. This provides doctors with crucial support when treating strokes.

Investors Include:

Cullom Capital, Listwin Ventures, Lennertz & Co., Vista Equity Partners.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more

Our available services for this company

Lifetime IncomeCharitable Remainder Trust

Tax SavingsDonor Advised Fund